Your browser doesn't support javascript.
loading
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study.
Birkeland, Kåre I; Bodegard, Johan; Norhammar, Anna; Kuiper, Josephina G; Georgiado, Elena; Beekman-Hendriks, Wendy L; Thuresson, Marcus; Pignot, Marc; Herings, Ron M C; Kooy, Adriaan.
Affiliation
  • Birkeland KI; Department of Transplantation Medicine, Division of Surgery, Inflammatory Medicine and Transplantation, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Bodegard J; AstraZeneca Nordic-Baltic, Oslo, Norway.
  • Norhammar A; Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Kuiper JG; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.
  • Georgiado E; Team Gesundheit GmbH, Essen, Germany.
  • Beekman-Hendriks WL; AstraZeneca, Den Haag, The Netherlands.
  • Thuresson M; Statisticon AB, Uppsala, Sweden.
  • Pignot M; Kantar Health GmbH, Munich, Germany.
  • Herings RMC; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.
  • Kooy A; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands.
Diabetes Obes Metab ; 21(4): 968-974, 2019 04.
Article in En | MEDLINE | ID: mdl-30537226
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Clinical Trials as Topic / Patient Selection / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2019 Type: Article Affiliation country: Norway
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Clinical Trials as Topic / Patient Selection / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2019 Type: Article Affiliation country: Norway